# Jiangsu Anbison Pharmaceutical Co., Ltd. – FDA Inspection, Jul 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-anbison-pharmaceutical-co-ltd/a3035420-47a3-4e76-9feb-4c3f8faa0583
Source feed: FDA_Inspections

> FDA inspection 1246817 of Jiangsu Anbison Pharmaceutical Co., Ltd., July 16, 2024. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246817
- Company Name: Jiangsu Anbison Pharmaceutical Co., Ltd.
- Inspection Date: 2024-07-16
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1220343 - 2023-08-18](https://www.keypedia.com/records/fda_inspections/jiangsu-anbison-pharmaceutical-co-ltd/d5e3c0b4-a844-438e-bf0d-a5fa8d06842a)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/jiangsu-anbison-pharmaceutical-co-ltd/f9324a6c-1ec8-40eb-8148-73c13ea386df

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
